Kathryn Guarini
At a glance: Kathryn Guarini is Director at Regeneron Pharmaceuticals (REGN). Their latest SEC Form 4, filed Nov 3, 2026, reported a sale of $360K. On file: 0 purchase lines ($0) and 3 sale lines ($1.0M).
Disclosed holdings: about $562K of REGN stock: 603 shares reported on their latest Form 4 (filed Nov 3, 2026), valued at the Nov 19, 2026 close of $932.53. This counts only REGN shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Regeneron Pharmaceuticals, Inc. (REGN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Kathryn Guarini's InsiderPrint
3 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 3 times a year, typically $340K a trade; most sales are on a pre-planned 10b5-1 schedule.
- Bump outward: a purchase (0)
- Dent inward: a sale (3)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Pedro R. BuhigasChief Information Officer · KGS · 100% match
- Christopher L. SchremserCTO · WAY · 100% match
- Christopher T. HandmanGeneral Counsel · ROKU · 100% match
- Wendell WierengaDirector · CYTK · 100% match
- Michael John ShortPresident · CHRW · 100% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 400603 held (−40%) | $900.00 | $360K | +3.6% |
| Sep 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 400603 held (−40%) | $850.00 | $340K | +9.7% |
| Aug 12SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 400603 held (−40%) | $800.00 | $320K | +16.6% |
- Sell
Director Kathryn Guarini sold $360K of REGN at $900.00 — cuts the stake by 40%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Kathryn Guarini sold $340K of REGN at $850.00 — cuts the stake by 40%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Kathryn Guarini sold $320K of REGN at $800.00 — cuts the stake by 40%; pre-scheduled 10b5-1 plan sale.
Follow Kathryn Guarini
Get one email when Kathryn Guarini files a new purchase or sale. Free.
At most one email a day about Kathryn Guarini, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.